Alice L Yu Selected Research

Protein Isoforms (Isoforms)

1/2017	HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.
4/2007	Hypoxia/reoxygenation and TGF-beta increase alphaB-crystallin expression in human optic nerve head astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alice L Yu Research Topics

Disease

56	Neoplasms (Cancer) 12/2023 - 11/2002
33	Neuroblastoma 08/2023 - 05/2002
24	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2008
6	Pain (Aches) 01/2020 - 01/2009
6	Macular Degeneration (Age-Related Maculopathy) 12/2014 - 04/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2010 - 03/2002
5	Infections 01/2017 - 06/2006
5	Glaucoma 01/2015 - 11/2008
4	Fever (Fevers) 12/2022 - 01/2009
4	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2011
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2006 - 03/2002
3	Cholangiocarcinoma 12/2023 - 01/2022
3	Hypersensitivity (Allergy) 12/2022 - 09/2010
3	Hypotension (Low Blood Pressure) 12/2022 - 01/2009
3	Hyperalgesia 01/2020 - 04/2010
3	Capillary Leak Syndrome 01/2018 - 01/2009
3	Hypoxia (Hypoxemia) 01/2017 - 04/2007
3	Kidney Neoplasms (Kidney Cancer) 01/2017 - 08/2013
3	Leukemia 10/2012 - 11/2002
2	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2017
2	Disease Progression 01/2022 - 05/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 08/2013
2	Residual Neoplasm 12/2014 - 09/2013
2	Optic Nerve Diseases (Optic Neuropathy) 03/2013 - 01/2012
2	Lung Neoplasms (Lung Cancer) 01/2013 - 06/2007
1	Genomic Instability 12/2023
1	Carcinogenesis 01/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2023
1	Mouth Neoplasms (Oral Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

15	dinutuximabIBA 01/2023 - 01/2009
14	Globo-HIBA 06/2023 - 08/2008
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2004
9	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2009
9	Monoclonal AntibodiesIBA 01/2017 - 04/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 04/2007
8	Polysaccharides (Glycans)IBA 01/2021 - 08/2008
8	GlycolipidsIBA 11/2020 - 06/2007
7	Interleukin-2 (IL2)IBA 12/2022 - 01/2009
7	Isotretinoin (Accutane)FDA LinkGeneric 01/2018 - 09/2010
6	Aldehyde DehydrogenaseIBA 01/2023 - 10/2011
6	AntioxidantsIBA 12/2014 - 04/2008
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2010
4	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2004
4	GlycosphingolipidsIBA 06/2023 - 10/2016
4	AntigensIBA 01/2023 - 06/2006
4	CeramidesIBA 01/2023 - 12/2014
4	LigandsIBA 01/2023 - 01/2017
4	CarbohydratesIBA 01/2023 - 08/2008
4	VaccinesIBA 01/2022 - 08/2008
4	CytokinesIBA 01/2021 - 06/2007
4	Galactosylceramides (Galactocerebrosides)IBA 02/2014 - 04/2011
4	AntibodiesIBA 01/2014 - 08/2008
3	3-Iodobenzylguanidine (Iobenguane)IBA 08/2023 - 05/2012
3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2017
3	LipidsIBA 01/2021 - 01/2017
3	EpitopesIBA 01/2020 - 08/2008
3	englerin AIBA 01/2017 - 08/2013
3	VimentinIBA 08/2014 - 10/2011
2	Cadherins (E-Cadherin)IBA 12/2023 - 10/2011
2	EnzymesIBA 01/2023 - 01/2017
2	temsirolimus FDA Link 01/2023 - 01/2017
2	globo H-KLH vaccineIBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 02/2013
2	Small Interfering RNA (siRNA)IBA 01/2021 - 05/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2002
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 12/2012
2	Complement System Proteins (Complement)IBA 01/2021 - 04/2010
2	Hormones (Hormone)IBA 07/2020 - 01/2020
2	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2004
2	Protein Isoforms (Isoforms)IBA 01/2017 - 04/2007
2	Plant ExtractsIBA 01/2017 - 08/2013
2	Peptides (Polypeptides)IBA 01/2016 - 04/2012
2	Phosphotransferases (Kinase)IBA 08/2013 - 10/2004
2	Stage-Specific Embryonic AntigensIBA 02/2013 - 08/2008
2	MicroRNAs (MicroRNA)IBA 01/2013 - 10/2010
2	GangliosidesIBA 12/2012 - 04/2010
2	cluvenoneIBA 10/2012 - 11/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 02/2009 - 04/2007
2	alpha-galactosylceramideIBA 08/2008 - 06/2007
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2023
1	Recombinant DNA (Recombinant DNA Research)IBA 12/2023
1	TransposasesIBA 12/2023
1	ChromatinIBA 12/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Mucin-4IBA 01/2023
1	matrigelIBA 12/2022
1	NucleophosminIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022

Therapy/Procedure

36	Therapeutics 08/2023 - 05/2002
20	Immunotherapy 01/2023 - 08/2008
5	Drug Therapy (Chemotherapy) 08/2023 - 03/2002
3	Precision Medicine 01/2022 - 01/2022
3	Stem Cell Transplantation 09/2013 - 09/2010
2	Induction Chemotherapy 11/2019 - 09/2013
2	Radiotherapy 07/2019 - 09/2013
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013 - 01/2009
1	Transplantation 08/2023